Details for Patent: 10,143,693
✉ Email this page to a colleague
Which drugs does patent 10,143,693 protect, and when does it expire?
Patent 10,143,693 protects INVEGA TRINZA and is included in one NDA.
This patent has forty-nine patent family members in twenty-six countries.
Summary for Patent: 10,143,693
Title: | Dosing regimen for missed doses for long-acting injectable paliperidone esters |
Abstract: | The present application provides a method for treating patients in need of psychiatric treatment, wherein said patient is being treated with the 3-month formulation of paliperidone palmitate and fails to take the next scheduled dose of the 3-month formulation of paliperidone palmitate. |
Inventor(s): | Gopal; Srihari (Belle Mead, NJ), Ravenstijn; Paulien Gerarda Maria (Waalre, NL), Russu; Alberto (Lange Nieuwstraat, BE), Samtani; Mahesh Narain (Flemington, NJ) |
Assignee: | Janssen Pharmaceuticals, Inc. (Beerse, BE) |
Application Number: | 15/090,889 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,143,693 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 10,143,693
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Janssen Pharms | INVEGA TRINZA | paliperidone palmitate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207946-001 | May 18, 2015 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | REINITIATION OF SCHIZOPHRENIA TREATMENT FOLLOWING A MISSED DOSE 4-9 MONTHS AGO | ⤷ Try a Trial | ||||
Janssen Pharms | INVEGA TRINZA | paliperidone palmitate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207946-001 | May 18, 2015 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | REINITIATION OF SCHIZOPHRENIA TREATMENT FOLLOWING A MISSED DOSE MORE THAN 9 MONTHS AGO | ⤷ Try a Trial | ||||
Janssen Pharms | INVEGA TRINZA | paliperidone palmitate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207946-002 | May 18, 2015 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | REINITIATION OF SCHIZOPHRENIA TREATMENT FOLLOWING A MISSED DOSE MORE THAN 9 MONTHS AGO | ⤷ Try a Trial | ||||
Janssen Pharms | INVEGA TRINZA | paliperidone palmitate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207946-002 | May 18, 2015 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | REINITIATION OF SCHIZOPHRENIA TREATMENT FOLLOWING A MISSED DOSE 4-9 MONTHS AGO | ⤷ Try a Trial | ||||
Janssen Pharms | INVEGA TRINZA | paliperidone palmitate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207946-003 | May 18, 2015 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | REINITIATION OF SCHIZOPHRENIA TREATMENT FOLLOWING A MISSED DOSE 4-9 MONTHS AGO | ⤷ Try a Trial | ||||
Janssen Pharms | INVEGA TRINZA | paliperidone palmitate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207946-003 | May 18, 2015 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | REINITIATION OF SCHIZOPHRENIA TREATMENT FOLLOWING A MISSED DOSE MORE THAN 9 MONTHS AGO | ⤷ Try a Trial | ||||
Janssen Pharms | INVEGA TRINZA | paliperidone palmitate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207946-004 | May 18, 2015 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | REINITIATION OF SCHIZOPHRENIA TREATMENT FOLLOWING A MISSED DOSE 4-9 MONTHS AGO | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,143,693
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2016244801 | ⤷ Try a Trial | |||
Australia | 2020239611 | ⤷ Try a Trial | |||
Australia | 2022221405 | ⤷ Try a Trial | |||
Brazil | 112017021383 | ⤷ Try a Trial | |||
Canada | 2925908 | ⤷ Try a Trial | |||
Canada | 3088401 | ⤷ Try a Trial | |||
Cyprus | 1123203 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |